EUVIMEDEUVIMED entdecken
Crossref

The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma

Olivia Pierog iD, Taylor Craig, Jacky Jennings, Michael J Borowitz, Ananya Munjal, Mariah Owusu-Agyei, David Weiner, J David Peske, Suman Paul, Sima Rozati iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.20060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Olivia Pierog und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Cutaneous, Skin Neoplasms, Receptors, Antigen, T-Cell, alpha-beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identifying aberrant T lymphocytes in peripheral blood is essential for diagnosing Sezary syndrome (SS) and is a prognostic indicator in mycosis fungoides (MF). Flow cytometry using a T‐cell receptor constant beta‐1 chain (TRBC1)‐targeting antibody provides a refined approach for detecting T‐cell clonality. We evaluated the performance of the TRBC1 antibody assay (TRBC1‐aa) in 164 patients, compared to standard flow cytometry methods for assessing T‐cell aberrancy, demonstrating 92.3% sensitivity and 83.5% specificity. TRBC1‐aa accurately excluded clonality in 100% of benign inflammatory dermatoses and improved the detection of residual blood involvement earlier than standard flow cytometry in 66.7% of SS and 25.0% of advanced‐stage MF patients on systemic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, T-Cell, CutaneousSkin NeoplasmsReceptors, Antigen, T-Cell, alpha-betaHumansMiddle AgedFlow CytometryMaleFemaleAgedMycosis FungoidesAdultSezary SyndromeAged, 80 and overSensitivity and Specificity

Stichwörter der Autor:innen

Sezary syndromeT‐cell lymphomaT‐cell receptorclonal analysismolecular diagnostics

Substanzen

Receptors, Antigen, T-Cell, alpha-beta

Autor:innen und Institutionen

  • Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Division of Haematological Malignancies and Bone Marrow Transplantation, Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Olivia Pierog, Sima Rozati

Förderung

  • NCI NIH HHS

Zitieren

APA

Pierog, O., Craig, T., Jennings, J., Borowitz, M. J., Munjal, A., Owusu-Agyei, M., Weiner, D., Peske, J. D., Paul, S., & Rozati, S. (2025). The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.20060

Vancouver

Pierog O, Craig T, Jennings J, Borowitz MJ, Munjal A, Owusu-Agyei M, et al. The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma. British Journal of Haematology. 2025. doi:10.1111/bjh.20060

BibTeX
@article{Pierog2025,
  author = {Pierog, Olivia and Craig, Taylor and Jennings, Jacky and Borowitz, Michael J and Munjal, Ananya and Owusu-Agyei, Mariah and Weiner, David and Peske, J David and Paul, Suman and Rozati, Sima},
  title = {The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.20060}
}
Kostenlos starten →